GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **976 - 1000** of **4050** in total

« First

‹ Prev

…

36

37

38

39

40

41

42

43

44

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgG	Patient 1	6	moderate	G00057MO	58
IgM	Patient 1	10	moderate	G53168IY	58
IgM	Patient 1	22	moderate	G00065MO	58
IgM	Patient 1	22	moderate	G76355TG	58
IgG	Patient 2	15	mild	G53168IY	58
IgG	Patient 2	24	mild	G42346AP	58
IgM	Patient 2	15	mild	G00048MO	58
IgM	Patient 1	6	moderate	G41200QS	58
IgM	Patient 1	6	moderate	G61399NC	58
IgG	Patient 3	-180	mild	G08520NM	58
IgG	Patient 3	-180	mild	G16579HJ	58
IgG	Patient 3	-180	mild	G61399NC	58
IgG	Patient 3	-180	mild	G76355TG	58
IgM	Patient 3	-180	mild	G94576MN	58
IgG	Patient 3	11	mild	G96881BQ	58
IgG	Patient 4	12	mild	G73271MD	58
IgG	Patient 4	12	mild	G92022ML	58
IgG	Patient 1	10	moderate	G80587NA	59
IgM	Patient 1	10	moderate	G75896PD	59
IgG	Patient 2	24	mild	G53168IY	59
IgG	Patient 1	6	moderate	G86156UJ	59
IgM	Patient 1	6	moderate	G91237TK	59
IgM	Patient 1	6	moderate	G96557TJ	59
IgM	Patient 1	6	moderate	G98240FC	59
IgG	Patient 3	-180	mild	G48898TH	59